Dudediligence.

Scholar Rock Holding Corporation

SRRKNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price
FilingsNewest: 8-K, Regulation FD disclosureSep 15 →InsidersNo open-market buys. 13 insiders sold $19.4M, 22 of 38 sales on a 10b5-1 plan.→HoldersFMR 14.8%Siren 7.9%BlackRock 7.8%→PeersClosest companies: APGE, MREO, VRDN→

From the filings

Figures

Revenue
$0.00last 12 months
Net income
−$408.6Mlast 12 months
Operating cash flow
−$303.5Mlast 12 months
Cash and equivalents
$437.1Mat the last balance sheet
Total debt
$196.2Mat the last balance sheet
Shares outstanding
121.6M shareson issue
Every year and quarter →